Health

Immunocore announces publication of phase 3 data comparing tebentafusp with …

In addition, the European Medicine Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) accepted Immunocore's Marketing Authorisation …

Read more @ finance.yahoo.com

Back to top button